Rxivist logo

The relative contributions of infectious and mitotic spread to HTLV-1 persistence

By Daniel J Laydon, Vikram Sunkara, Lies Boelen, Charles R M Bangham, Becca Asquith

Posted 09 Oct 2019
bioRxiv DOI: 10.1101/799197 (published DOI: 10.1371/journal.pcbi.1007470)

Human T-lymphotropic virus type-1 (HTLV-1) persists within hosts via infectious spread ( de novo infection) and mitotic spread (infected cell proliferation), creating a population structure of multiple clones (infected cell populations with identical genomic proviral integration sites). The relative contributions of infectious and mitotic spread to HTLV-1 persistence are unknown, and will determine the efficacy of different approaches to treatment. The prevailing view is that infectious spread is negligible in HTLV-1 proviral load maintenance beyond early infection. However, in light of recent high-throughput data on the abundance of HTLV-1 clones, and recent estimates of HTLV-1 clonal diversity that are substantially higher than previously thought (typically between 10 4 and 10 5 HTLV-1 + T cell clones in the body of an asymptomatic carrier or patient with HAM/TSP), ongoing infectious spread during chronic infection remains possible. We estimate the ratio of infectious to mitotic spread using a hybrid model of deterministic and stochastic processes, fitted to previously published HTLV-1 clonal diversity estimates. We investigate the robustness of our estimates using two alternative methods. We find that, contrary to previous belief, infectious spread persists during chronic infection, even after HTLV-1 proviral load has reached its set point, and we estimate that between 100 and 200 new HTLV-1 clones are created and killed every day. We find broad agreement between all three methods. The risk of HTLV-1-associated malignancy and inflammatory disease is strongly correlated with proviral load, which in turn is correlated with the number of HTLV-1-infected clones, which are created by de novo infection. Our results therefore imply that suppression of de novo infection may reduce the risk of malignant transformation.

Download data

  • Downloaded 219 times
  • Download rankings, all-time:
    • Site-wide: 126,830
    • In immunology: 3,775
  • Year to date:
    • Site-wide: 157,192
  • Since beginning of last month:
    • Site-wide: 148,974

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide